Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James McKay

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Ebiomedicine|May 25, 2019
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancerPatrice Hodonou Avogbe, Arnaud Manel, Emmanuel Vian, et al.
Plos Genetics|February 2, 2018
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma riskRosalie G Waller, Todd M Darlington, Xiaomu Wei, et al.
Ebiomedicine|February 22, 2020
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort StudyMd Ismail Hosen, Mahdi Sheikh, Maria Zvereva, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Scientific Reports|August 5, 2016
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization studyRobert Carreras-Torres, Philip C Haycock, Caroline L Relton, et al.
Carcinogenesis|June 21, 2018
Genome-wide association study of familial lung cancerJinyoung Byun, Ann G Schwartz, Christine Lusk, et al.
Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.
American Journal of Hematology|January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome studyCharles Dumontet, Delphine Demangel, Perrine Galia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.
International Journal of Cancer|July 13, 2017
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortiaFangyi Gu, Han Zhang, Paula L Hyland, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Ebiomedicine|May 25, 2019
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancerPatrice Hodonou Avogbe, Arnaud Manel, Emmanuel Vian, et al.
Plos Genetics|February 2, 2018
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma riskRosalie G Waller, Todd M Darlington, Xiaomu Wei, et al.
Ebiomedicine|February 22, 2020
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort StudyMd Ismail Hosen, Mahdi Sheikh, Maria Zvereva, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Scientific Reports|August 5, 2016
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization studyRobert Carreras-Torres, Philip C Haycock, Caroline L Relton, et al.
Carcinogenesis|June 21, 2018
Genome-wide association study of familial lung cancerJinyoung Byun, Ann G Schwartz, Christine Lusk, et al.
Nature Communications|April 29, 2024
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancersKarl Smith-Byrne, Åsa Hedman, Marios Dimitriou, et al.
American Journal of Hematology|January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome studyCharles Dumontet, Delphine Demangel, Perrine Galia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.
International Journal of Cancer|July 13, 2017
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortiaFangyi Gu, Han Zhang, Paula L Hyland, et al.
Pageof 16